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Abstract
Background: The purpose of this study is to investigate the effects of intraoperative infusion of branched-chain
amino acids (BCAA) in patients undergoing gastrointestinal tumor surgery.
Methods: Sixty-one patients with gastrointestinal tumors undergoing gastrointestinal surgery were enrolled and
randomly assigned to receive an intraoperative infusion of 3-compound BCAA solution (N = 20), amino acids (AA)
solution (N = 21), or normal saline (NS) (N = 20). Nasopharyngeal temperature, blood glucose (BG), plasma insulin,
and blood free fatty acids (FFA) concentrations were measured at 30 min before and 10 min after induction (T0,T1),
30 min and 2 h after skin incision (T2,T3), and 1 h after tracheal extubation (T4). Intensity of shivering and pain was
accessed at 1 h after extubation.
Results: The temperature in the BCAA and AA group was significantly higher than that in the NS group at T4
(P = 0.014 and 0.033). The incidence of shivering in the BCAA and AA group was significantly lower than in the
NS group (P = 0.027 and 0.012). BG increased in AA group at T3 and T4 (P = 0.001 and 0.045). The plasma insulin
concentration increased in the BCAA and AA group from T1 to T3. The plasma FFA concentrations in the BCAA
group were lower than in the AA and NS group from T2 to T4.
Conclusions: Intraoperative BCAA and AA infusion alleviated postoperative hypothermia and shivering. BCAA
infusion also inhibited fat mobilization, without adversely affecting blood glucose.
Trial registration: ChiCTR-TRC-14004668
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Background
During anesthesia and surgery, redistribution hypothermia
occurs as peripheral vessels dilate, and impaired hypothal-
amic thermoregulation further worsens the hypothermia
[1, 2]. Thereafter, core body temperature gradually de-
clines as heat is lost from the surface of the body, and the
production of heat slows [3–6]. Furthermore, the stress of
surgery and anesthesia leads to a series of changes at the
metabolic level and in the neuro-endocrine axis [2, 7].
Catabolism exceeds anabolism, thereby increasing the
physiological burden of patients undergoing surgery.
Unlike other amino acids (AAs) that are metabo-
lized dominantly in the liver, the branched-chain
amino acids (BCAA), isoleucine, leucine, and valine
are uniquely metabolized primarily in the skeletal
muscle. Moreover, BCAAs can promote anabolism
without placing additional burdens on the liver. In
previous studies, infusions of compound intravenous
AA solutions have been shown to exhibit a thermo-
genic effect during anesthesia [8–10]. Therefore, we
hypothesized that intraoperative infusion of BCAA in-
stead of AAs could provide even more benefit to pa-
tients. The objective of our study was to investigate
the effects of intraoperative infusion of BCAA on
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The study was approved by the Ethics Committee of
Zhongshan Hospital, Fudan University (B2014-013) and
registered at www.chictr.org.cn (ChiCTR-TRC-14004668).
Written informed consent was obtained from all patients.
We screened a total of 69 consecutive patients (aged 18–
65 years and American Society of Anesthesiologist phys-
ical status classes I–II) scheduled to undergo GI surgery
(stomach or colorectal) at Zhongshan Hospital from May
to July 2014. Patients were excluded if they had a serum
albumin <35 g·L−1, anemia (hemoglobin <100 g·L−1), or
evidence of a major medical condition (such as diabetes
mellitus, thyroid disease, hepatic disease, or renal disease).
They were also excluded if they were receiving drugs
known to have metabolic effects, such as corticosteroids
or β-blockers. Only 61 patients fulfilled all criteria. They
were randomly assigned at a 1:1:1 ratio to one of three
groups using random number method: BCAA infusion
group (compound amino acid injection, BBCA Pharma-
ceutical Co. Ltd., Anhui, China; see Appendix), AA infu-
sion group (Aminoplasmal, B. Braun Melsungen AG,
Jiangsu, China; see in Appendix), and normal saline (NS)
infusion group (normal saline, Baxter Healthcare Co. Ltd.,
Shanghai, China). All patients underwent standard GI
preoperative procedures, including overnight fasting.
Patients scheduled for colorectal operations also
underwent bowel-cleansing procedures the day before
surgery. No premedications were given except intes-
tinal antibacterial drugs, which were started 3 days
preoperatively.
Anesthesia
Before the induction of general anesthesia, each pa-
tient received an epidural catheter between T8 and
T12, a central venous catheter, and a radial artery
catheter. Hemodynamic monitoring was performed
using a three-lead electrocardiogram monitor, finger
pulse oximetry, and continuous arterial pressure
measurement via the radial artery catheter.
General anesthesia was induced in all patients with
fentanyl 3 μg·kg−1, propofol 2 mg·kg−1, and lidocaine
60 mg, and rocuronium 0.6 mg·kg−1 was adminis-
tered to facilitate intubation. After tracheal intub-
ation, mechanical ventilation was initiated with 50 %
oxygen: 50 % air-gas mixture, and ventilation was
adjusted to maintain the end-tidal CO2 at 30–
40 mmHg. After induction, 6–10 mL of 0.5 % bupi-
vacaine was administered in increments through the epi-
dural catheter, and epidural anesthesia was maintained
with intermittent boluses of 3–5 mL every hour dur-
ing the operation. General anesthesia was maintained
with sevoflurane at a minimum alveolar concentration
of 0.8–0.9. Boluses of phenylephrine or ephedrine
were administered if necessary to maintain the heart
rate and arterial pressure within ±30 % of baseline.
Each patient received 0.125 % bupivacaine and fen-
tanyl 2 μg·mL−1 for patient-controlled epidural analgesia
postoperatively.
Experimental protocol
The operating room temperature was maintained at
21–23 °C. No other perioperative warming strategies
were used except the blood products that were
warmed to 42 °C if a transfusion was needed. A
forced-air warming system would be used as a res-
cue method, if the body core temperature dropped
below 35 °C. All patients were covered with two
layers of quilt postoperatively.
The AA infusion was diluted to 4.26 % with nor-
mal saline. The total dose of BCAA was calculated
as 5.6 mL·kg−1·h−1 according to the basal metabolic
rate, 4 kJ·kg−1·h−1. The intervention fluid (BCAA,
AA, or NS) was infused at a rate of 5.6 mL·kg−1·h−1.
In addition, Lactated Ringer’s solution (lot no.
S1401082; Baxter Healthcare Co. Ltd., Shanghai,
China) was administered at 4 mL·kg−1·h−1 as the
basal fluid infusion. All intervention fluids were in-
fused via a central venous catheter, using a Graseby
3500 pump (SIMS Graseby Ltd., Watford, UK). The
infusions were initiated at the beginning of induction
and discontinued when the patient was extubated.
The BCAA, AA, and NS solutions were prepared
by a specified investigator. The other investigators, all
health-care providers, and all patients were blinded to
the preparation procedure and were thereby unaware
of the group assignments.
Measurements
The core temperature was measured continuously
using a nasopharyngeal temperature probe (Datex-
Ohmeda Division, Instrumentarium Corp., Helsinki,
Finland) which was inserted from the nostril with
the distance from the philtrum to the tragus. Blood
samples were collected 30 min before induction (T0),
10 min after induction (T1), 30 min and 2 h after
skin incision (T2 and T3), and 1 h after extubation
(T4). Each blood sample was transferred immediately
to an EDTA tube and centrifuged at 4 °C until analyzed
within 24 h by an automatic biochemical analyzer (7080,
Hitachi, Japan) and automatic electrochemiluminescence
analyzer (Cobas e602, Roche, Swiss). At the same time
points, the blood glucose concentration was measured by
a glucose analyzer (One Touch Sure-step; LifeScan,
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Johnson & Johnson Medical Co. Ltd., Shanghai, China)
using a sample of blood obtained from the fingertips.
At 1 h after tracheal extubation, the intensity of shiv-
ering was assessed by a single investigator (who was
the same for each patient) using the Wrench grade
for post-anesthetic shivering [11] (Additional file 1:
Table S1), and the severity of pain was assessed using
a visual analog scale (with 0 =no pain and 10 =worst pain
imaginable) [12].
Sample size estimation and statistical analysis
In this study, the primary outcome measure was
nasopharyngeal temperature, and the secondary out-
come measures were blood glucose concentration and
circulating concentrations of plasma insulin and free
fatty acids (FFA). PASS 11.0 (NCSS, Kaysville, Utah,
USA) were used for sample size estimation and power
calculation. In previous studies [10], the standard
deviation of body temperature was approximately
0.1–0.2 °C, and the expected difference between
groups was approximately 0.3–0.5 °C; therefore, less
than nine patients in each group were calculated to
be sufficient for this outcome (power 80 %, α = 0.05).
On the basis of an expected difference in blood glu-
cose concentration of 1 mmol·L−1 between the two
groups (standard deviation =1 mmol·L−1; power 80 %,
α = 0.05), 17 patients in each group were calculated to
be sufficient for this study [10, 13, 14]. Thus, 20
patients in each group were deemed sufficient for this
study. Statistical analyses were performed using SPSS
20.0 (SPSS, Inc.) software. Categorical variables, in-
cluding gender and type of operation, were analyzed
using χ2 or Fisher’s exact test. Continuous variables
were analyzed using two-tailed general linear model
repeated measures analysis of variance. Probability (p)
values <0.05 were considered statistically significant.
Results
There were no baseline differences among the three
groups for gender, age, body mass index (BMI), type
of operation, duration of surgery, and anesthesia
(Table 1). The severity of pain 1 h after surgery
between the two groups did not reach statistical
significance. No patient received a blood transfusion
in this study. The mean postoperative hospitalization
days were 7.9 ± 1.8, 8.1 ± 1.9, and 8.6 ± 2.4 days for
the BCAA, AA, and NS groups, respectively. Only
one patient in the AA group suffered from bowel
leak in hospitalization within 30 days after operation.
The continuous data were normally distributed, with
homogeneity of variance (data not shown). The
baseline data (30 min before anesthesia) for core
temperature, blood glucose, plasma insulin, and FFA
level were not significantly different among the three
groups (Table 2).
The patients’ core temperature in both the BCAA and
NS groups slowly decreased during surgery while none
dropped below 35 °C. However, the mean temperature
in the BCAA and AA groups was significantly higher at
1 h after extubation than in the NS group (36.39, 36.34
vs 36.05, P = 0.029, power = 80.76 %) (Table 2). There
was no significant difference in incidence and intensity
of shivering (grade 0 vs grade ≥1) between the BCAA
and AA group. BCAA and AA groups were significantly
Table 1 Baseline characteristics of the three groups
BCAA (N = 20) AA (N = 21) NS (N = 20) P
Gender 0.509
Male 13 (65.0) 10 (47.6) 12 (60.0)
Female 7 (35.0) 11 (52.4) 8 (40.0)
Age (years) 56.5 (18 to 65) 58 (40 to 68) 52 (34 to 65) 0.313
BMI (kg/m2) 23.62 ± 2.33 23.32 ± 3.02 22.83 ± 2.33 0.594
Surgery typea 0.710
Gastric 8 (40.0) 10 (47.6) 7 (35.0)
Colorectal 12 (60.0) 11 (52.4) 13 (65.0)
Duration of surgery (min) 146.75 ± 2.92 147.14 ± 22.89 137.37 ± 36.41 0.428
Total volume of fluid (mL) 2615.00 ± 241.21 2504.76 ± 423.64 2457.90 ± 287.36 0.006
Amino acids
Non-BCAA (g) 0 26.35 ± 5.55 0
BCAA (g) 38.62 ± 7.75 11.29 ± 2.38 0
Data are mean ± standard deviation or number (percentage)
Abbreviations: BCAA branched-chain amino acids, BMI body mass index, NS normal saline, AA amino acid
aSurgeries were conducted open
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different from NS group (P values were 0.027 and 0.012,
respectively Table 3).
Blood glucose concentrations increased after the
induction of anesthesia in all three groups. There
were no significant differences between the BCAA
and NS groups over time, although the values in the
BCAA group seemed to be more stable than those
in the NS group. BG in the AA group peaked at T3
(7.61 mM) and were higher at T3 and T4 comparing
with the BCAA group (P = 0.001 and 0.045, power =
99.96). The plasma insulin concentration of BCAA
and AA groups began to increase at T1 and peaked
at T3. The plasma insulin in the NS group stayed in
baseline level during surgery. The insulin values
were significantly higher in BCAA and AA patients
than in NS patients from T1 to T4 (all P < 0.05,
power = 99.80, Table 2). Moreover, in AA patients,
the insulin level increased to 28.89 μU/mL at T3.
The FFA concentrations in the NS and AA groups
decreased at the beginning of anesthesia, hit a nadir
at 30 min after skin incision, and then slowly in-
creased until 1 h after extubation. By contrast,
plasma FFA concentrations in the BCAA group de-
creased from 10 min after induction to the end of
surgery and remained low thereafter (Table 2).
Discussion
Nutrients such as glucose, fatty acids, and AAs are not
usually administered intraoperatively because of the
stress response that typically accompanies anesthesia
Table 2 Changes in nasopharyngeal temperature and plasma concentrations of glucose, insulin, and free fatty acids
Factors Variables BCAA (N = 20) AA (N = 21) NS (N = 20) P*
T (°C) T0 36.77 ± 0.37 36.56 ± 0.35 36.61 ± 0.37 0.177
T1 36.51 ± 0.31 36.40 ± 0.35 36.35 ± 0.39 0.335
T2 36.21 ± 0.35 36.26 ± 0.35 36.16 ± 0.47 0.709
T3 35.89 ± 0.42 36.17 ± 0.36 35.82 ± 0.56 0.040
T4 36.39 ± 0.40 36.34 ± 0.34 36.05 ± 0.49 0.029
BG (mmol·L−1) T0 5.12 ± 0.89 5.11 ± 0.45 4.83 ± 0.92 0.436
T1 5.47 ± 0.78 5.48 ± 0.56 5.15 ± 1.02 0.349
T2 5.87 ± 0.92 6.32 ± 0.61 5.92 ± 1.39 0.297
T3 5.96 ± 0.95 7.61 ± 1.24 6.05 ± 2.07 0.001
T4 6.09 ± 1.33 7.21 ± 1.28 7.05 ± 1.84 0.045
Insulin (μU·mL−1) T0 4.38 ± 2.40 4.41 ± 3.69 3.34 ± 2.50 0.276
T1 6.85 ± 4.46 6.87 ± 5.46 3.17 ± 3.03 0.016
T2 6.86 ± 4.78 16.12 ± 12.25 2.18 ± 2.05 0.000
T3 12.72 ± 7.83 28.89 ± 21.10 2.57 ± 1.62 0.000
T4 10.56 ± 5.53 8.55 ± 6.09 4.03 ± 2.98 0.001
FFA (mmol·L−1) T0 0.86 ± 0.30 0.80 ± 0.37 0.96 ± 0.29 0.288
T1 0.66 ± 0.26 0.59 ± 0.25 0.78 ± 0.26 0.075
T2 0.47 ± 0.14 0.39 ± 0.16 0.59 ± 0.23 0.003
T3 0.42 ± 0.19 0.89 ± 0.30 0.74 ± 0.37 0.000
T4 0.37 ± 0.19 0.58 ± 0.24 0.86 ± 0.40 0.000
Data are represented as mean ± standard deviation. Italicized texts indicate significance
Abbreviations: T nasopharyngeal temperature, BG blood glucose, FFA free fatty acids, BCAA branched-chain amino acids, NS normal saline, AA amino acids, T0
30 min before induction, T1 10 min after induction (before skin incision), T2 and T3 30 min and 2 h after skin incision, T4 1 h after extubation
*P mean value among three groups (one way ANOVA)
Table 3 Shivering grades at 1 h after extubation
Group Grade
0 1 2 3 4
BCAA (N = 20) 14 5 1 0 0
AA (N = 21) 15 4 2 0 0
NS (N = 20) 7 4 5 3 1
In comparison of shivering grades (grade 0 vs grade ≥1), BCAA and AA groups
were significantly different from the NS group (P value were 0.027 and 0.012,
respectively.). There was no significant difference between BCAA and AA
groups (P = 0.920)
Abbreviations: BCAA branched-chain amino acids, AA amino acids, NS
normal saline
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and surgery [15]. However, recent studies have dem-
onstrated that administration of AAs can stimulate en-
ergy expenditure and enhance thermogenesis during
surgery and anesthesia [8, 9, 16–19]. Furthermore, the
optimal composition of intraoperative AAs remains
poorly understood. Our current results suggest that
BCAA administration can alleviate postoperative
shivering. Moreover, BCAA infusion had little influ-
ence on the blood glucose concentration, thereby sug-
gesting that it is safe during anesthesia and surgery
from this perspective.
In our previous study of patients undergoing sur-
gery under general anesthesia combined with epi-
dural block, the thermogenic effects of intraoperative
AAs infusion were not significant in the early part
of surgery; they were most obvious at 2 h after the
induction of anesthesia [14]. This was consistent
with our results. The current study, which was the
first randomized controlled trial to investigate the
thermogenic effects of BCAA in patients, showed
that BCAA infusion also had a delayed thermogenic
response. Furthermore, the BCAA infusion was also
noted to decrease the incidence of postoperative
shivering as AA infusion did.
Previous studies in humans [20], as well as in an
animal model [10], have reported substantial in-
creases in blood glucose and insulin concentrations
during the administration of AAs. This phenomenon
was reproducible in our study. Although our current
results demonstrated a statistically significant in-
crease in blood glucose while infusing BCAA, the in-
crease was not as dramatic as that in the AA group.
Moreover, in the AA group, insulin level increased
significantly as well. Previous studies demonstrated
that plasma AA concentration was closely associated
with insulin resistance [21–24]. Several experiments
on human and rats suggested that the increased
plasma AA concentration reduced insulin-induced
peripheral glucose disposal by interfering with muscle
glucose transport and phosphorylation [25, 26]. This
phenomenon was observed in the present study. In the
BCAA and AA groups, although plasma insulin level
largely increased after BCAA or AA infusion, the plasma
glucose concentration was still upregulated. In other
words, glucose utilization decreased. In clinical practice, a
blood glucose concentration of 6–10 mmol·L−1 would be
considered acceptable. Our study demonstrated that
BCAA infusion had less effect on blood glucose than
AA did.
As a consequence of the endocrine response to
stress, lipid mobilization is enhanced [27]. In the
current study, the FFA concentration in the BCAA
group declined during surgery, whereas the FFA con-
centration in the NS group decreased at T2 but
subsequently rose at T3. This may reflect a decreased
lipid mobilization effect of BCAA. Although detailed
mechanisms must still be uncovered, one explanation
may be that lipolysis is suppressed by the enhanced
insulin secretion trigged by BCAA [28]. In the AA
group, FFA concentration was unstable during sur-
gery. This might due to the influence of complicated
component of AA on lipid mobilization.
Limitations of this study should be clarified. Al-
though the sample size estimation showed that our
number of subjects was adequate for statistical ana-
lysis, our sample size was small and validation is re-
quired in a larger population. Furthermore, we did
not obtain a muscle biopsy to investigate the direct
results of BCAA metabolism in the skeletal muscle,
and further studies, including invasive approaches for
studying BCAA metabolism, are still needed. Also,
the long-term complications of patients who under-
went GI surgery were not included in this study. It
remains unknown whether the effect of BCAA on in-
sulin induction could have detrimental effect on type
2 diabetes or even pre-diabetic patients.
Conclusions
In conclusion, our findings indicate that an intraopera-
tive infusion of BCAA can alleviate hypothermia and the
intensity of shivering after GI surgery. It can also inhibit
fat mobilization, without adversely affecting blood glu-
cose concentrations in our cohort. Further multicenter
external validation is needed.
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Appendix
Table 4 Composition of the 3-compound branched-chain
amino acids injection (per 1000 ml)




Total amino acids 42.60
Osmotic pressure: approximately 382 mOsm/L
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Total amino acids 100
Osmotic pressure: approximately 875 mOsm/L
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